Evidence-based clinical standard for the diagnosis and treatment of candidemia in critically ill patients in the intensive care unit
Jorge Alberto Cortés(Universidad de Costa Rica), Arnaldo Lopes Colombo(Universidade Federal de São Paulo), Flávio Queiroz‐Telles(Hospital de Clínicas Universidade Federal do Paraná), Laura Cristina Nócua-Báez(Universidad Nacional de Colombia), Jeannete Zurita(Pontificia Universidad Católica del Ecuador), Carmelo José Espinosa‐Almanza(Universidad Nacional de Colombia), Moacyr Silva(Hospital Israelita Albert Einstein), Ricardo Rabagliati(Pontificia Universidad Católica de Chile), Rita A Rojas-Fermin(Instituto Tecnológico de Santo Domingo), Fernando Riera(Fundacion Allende), Martha Carolina Valderrama-Ríos(Hospital Universitario Nacional de Colombia), Dora Corzo-León(University of Exeter), Carlos Álvarez(Pontificia Universidad Javeriana), Cándida Díaz‐Brochero(Pontificia Universidad Javeriana), J. L. Finquelievich(Universidad de Buenos Aires), Patricia Cornejo‐Juárez(Instituto Nacional de Cancerología), A. Sánchez Hernández(Hospital Punta Pacifica), Luis E. Cuéllar(Instituto Nacional de Enfermedades Neoplásicas), Paula M. Peçanha‐Pietrobom(Universidade Federal de São Paulo), Rafael Ricardo Robles-Torres(Universidad Nacional de Colombia), Márcio Nucci(Universidade Federal do Rio de Janeiro)
Cited by 5
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Simultaneous Emergence of Multidrug-Resistant <i>Candida auris</i> on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
|Clinical Infectious Diseases|2016|1.6k
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
|The Lancet|2007|689
Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis
|Clinical Infectious Diseases|2007|632